Industry Research Reports
Home > Reports > Medical Devices & Consumables > 25G Transconjunctival Sutureless Vitrectomy System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
25G Transconjunctival Sutureless Vitrectomy System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Medical Devices & Consumables
Published Date: 2026-01-08
Pages: 97 Pages
Report ld: 5612516
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for 25G Transconjunctival Sutureless Vitrectomy System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on 25G Transconjunctival Sutureless Vitrectomy System cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
The North American market for 25G Transconjunctival Sutureless Vitrectomy System was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for 25G Transconjunctival Sutureless Vitrectomy System was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for 25G Transconjunctival Sutureless Vitrectomy System was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the 25G Transconjunctival Sutureless Vitrectomy System market include Alcon, Bausch + Lomb, Dutch Ophthalmic Research Center, NIDEK, Suzhou Synergy Medical Technology, Shanghai Fosun Pharmaceutical Group, Beijing Kangruide Medical Technology, Shanghai New Vision Ophthalmic Equipment, Shenzhen Ophthalmic Equipment, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for 25G Transconjunctival Sutureless Vitrectomy System, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The 25G Transconjunctival Sutureless Vitrectomy System market size, estimations, and forecasts are presented in terms of sales volume (Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding 25G Transconjunctival Sutureless Vitrectomy System.
MARKET SEGMENTATION
By Company
- Alcon
- Bausch + Lomb
- Dutch Ophthalmic Research Center
- NIDEK
- Suzhou Synergy Medical Technology
- Shanghai Fosun Pharmaceutical Group
- Beijing Kangruide Medical Technology
- Shanghai New Vision Ophthalmic Equipment
- Shenzhen Ophthalmic Equipment
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Standard
- Combination
Segment by Application
- Ophthalmology
- Other
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the 25G Transconjunctival Sutureless Vitrectomy System manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents 25G Transconjunctival Sutureless Vitrectomy System sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents 25G Transconjunctival Sutureless Vitrectomy System sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 25G Transconjunctival Sutureless Vitrectomy System Product Introduction
1.2 Global 25G Transconjunctival Sutureless Vitrectomy System Market Size Forecast
1.2.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value (2021–2032)
1.2.2 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume (2021–2032)
1.2.3 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Price (2021–2032)
1.3 25G Transconjunctival Sutureless Vitrectomy System Market Trends & Drivers
1.3.1 25G Transconjunctival Sutureless Vitrectomy System Industry Trends
1.3.2 25G Transconjunctival Sutureless Vitrectomy System Market Drivers & Opportunities
1.3.3 25G Transconjunctival Sutureless Vitrectomy System Market Challenges
1.3.4 25G Transconjunctival Sutureless Vitrectomy System Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global 25G Transconjunctival Sutureless Vitrectomy System Players Revenue Ranking (2025)
2.2 Global 25G Transconjunctival Sutureless Vitrectomy System Revenue by Company (2021–2026)
2.3 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume Ranking of Players (2025)
2.4 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume by Company (2021–2026)
2.5 Global 25G Transconjunctival Sutureless Vitrectomy System Average Price by Company (2021–2026)
2.6 Key Manufacturers 25G Transconjunctival Sutureless Vitrectomy System Manufacturing Base and Headquarters
2.7 Key Manufacturers 25G Transconjunctival Sutureless Vitrectomy System Product Offerings
2.8 Key Manufacturers Start of Mass Production of 25G Transconjunctival Sutureless Vitrectomy System
2.9 25G Transconjunctival Sutureless Vitrectomy System Market Competitive Analysis
2.9.1 25G Transconjunctival Sutureless Vitrectomy System Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by 25G Transconjunctival Sutureless Vitrectomy System Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on 25G Transconjunctival Sutureless Vitrectomy System revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation 25G Transconjunctival Sutureless Vitrectomy System Market Classification
3.1 Introduction by Type
3.1.1 Standard
3.1.2 Combination
3.1.3 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Type
3.1.3.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value, by Type (2021–2032)
3.1.3.3 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value, by Type (%), 2021–2032
3.1.4 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume by Type
3.1.4.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume, by Type (2021–2032)
3.1.4.3 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume, by Type (%), 2021–2032
3.1.5 Global 25G Transconjunctival Sutureless Vitrectomy System Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Ophthalmology
4.1.2 Other
4.2 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Application
4.2.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value, by Application (2021–2032)
4.2.3 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value, by Application (%), 2021–2032
4.3 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume by Application
4.3.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume, by Application (2021–2032)
4.3.3 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume, by Application (%), 2021–2032
4.4 Global 25G Transconjunctival Sutureless Vitrectomy System Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Region
5.1.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Region (2021–2026)
5.1.3 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Region (2027–2032)
5.1.4 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Region (%), 2021–2032
5.2 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume by Region
5.2.1 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume by Region (2021–2026)
5.2.3 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume by Region (2027–2032)
5.2.4 Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume by Region (%), 2021–2032
5.3 Global 25G Transconjunctival Sutureless Vitrectomy System Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America 25G Transconjunctival Sutureless Vitrectomy System Sales Value, 2021–2032
5.4.2 North America 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe 25G Transconjunctival Sutureless Vitrectomy System Sales Value, 2021–2032
5.5.2 Europe 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific 25G Transconjunctival Sutureless Vitrectomy System Sales Value, 2021–2032
5.6.2 Asia Pacific 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America 25G Transconjunctival Sutureless Vitrectomy System Sales Value, 2021–2032
5.7.2 South America 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa 25G Transconjunctival Sutureless Vitrectomy System Sales Value, 2021–2032
5.8.2 Middle East & Africa 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions 25G Transconjunctival Sutureless Vitrectomy System Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions 25G Transconjunctival Sutureless Vitrectomy System Sales Value and Sales Volume
6.2.1 Key Countries/Regions 25G Transconjunctival Sutureless Vitrectomy System Sales Value, 2021–2032
6.2.2 Key Countries/Regions 25G Transconjunctival Sutureless Vitrectomy System Sales Volume, 2021–2032
6.3 United States
6.3.1 United States 25G Transconjunctival Sutureless Vitrectomy System Sales Value, 2021–2032
6.3.2 United States 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Type (%), 2025 vs 2032
6.3.3 United States 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe 25G Transconjunctival Sutureless Vitrectomy System Sales Value, 2021–2032
6.4.2 Europe 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China 25G Transconjunctival Sutureless Vitrectomy System Sales Value, 2021–2032
6.5.2 China 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Type (%), 2025 vs 2032
6.5.3 China 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan 25G Transconjunctival Sutureless Vitrectomy System Sales Value, 2021–2032
6.6.2 Japan 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea 25G Transconjunctival Sutureless Vitrectomy System Sales Value, 2021–2032
6.7.2 South Korea 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia 25G Transconjunctival Sutureless Vitrectomy System Sales Value, 2021–2032
6.8.2 Southeast Asia 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India 25G Transconjunctival Sutureless Vitrectomy System Sales Value, 2021–2032
6.9.2 India 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Type (%), 2025 vs 2032
6.9.3 India 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Alcon
7.1.1 Alcon Company Information
7.1.2 Alcon Introduction and Business Overview
7.1.3 Alcon 25G Transconjunctival Sutureless Vitrectomy System Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Alcon 25G Transconjunctival Sutureless Vitrectomy System Product Offerings
7.1.5 Alcon Recent Developments
7.2 Bausch + Lomb
7.2.1 Bausch + Lomb Company Information
7.2.2 Bausch + Lomb Introduction and Business Overview
7.2.3 Bausch + Lomb 25G Transconjunctival Sutureless Vitrectomy System Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Bausch + Lomb 25G Transconjunctival Sutureless Vitrectomy System Product Offerings
7.2.5 Bausch + Lomb Recent Developments
7.3 Dutch Ophthalmic Research Center
7.3.1 Dutch Ophthalmic Research Center Company Information
7.3.2 Dutch Ophthalmic Research Center Introduction and Business Overview
7.3.3 Dutch Ophthalmic Research Center 25G Transconjunctival Sutureless Vitrectomy System Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Dutch Ophthalmic Research Center 25G Transconjunctival Sutureless Vitrectomy System Product Offerings
7.3.5 Dutch Ophthalmic Research Center Recent Developments
7.4 NIDEK
7.4.1 NIDEK Company Information
7.4.2 NIDEK Introduction and Business Overview
7.4.3 NIDEK 25G Transconjunctival Sutureless Vitrectomy System Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 NIDEK 25G Transconjunctival Sutureless Vitrectomy System Product Offerings
7.4.5 NIDEK Recent Developments
7.5 Suzhou Synergy Medical Technology
7.5.1 Suzhou Synergy Medical Technology Company Information
7.5.2 Suzhou Synergy Medical Technology Introduction and Business Overview
7.5.3 Suzhou Synergy Medical Technology 25G Transconjunctival Sutureless Vitrectomy System Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Suzhou Synergy Medical Technology 25G Transconjunctival Sutureless Vitrectomy System Product Offerings
7.5.5 Suzhou Synergy Medical Technology Recent Developments
7.6 Shanghai Fosun Pharmaceutical Group
7.6.1 Shanghai Fosun Pharmaceutical Group Company Information
7.6.2 Shanghai Fosun Pharmaceutical Group Introduction and Business Overview
7.6.3 Shanghai Fosun Pharmaceutical Group 25G Transconjunctival Sutureless Vitrectomy System Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Shanghai Fosun Pharmaceutical Group 25G Transconjunctival Sutureless Vitrectomy System Product Offerings
7.6.5 Shanghai Fosun Pharmaceutical Group Recent Developments
7.7 Beijing Kangruide Medical Technology
7.7.1 Beijing Kangruide Medical Technology Company Information
7.7.2 Beijing Kangruide Medical Technology Introduction and Business Overview
7.7.3 Beijing Kangruide Medical Technology 25G Transconjunctival Sutureless Vitrectomy System Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Beijing Kangruide Medical Technology 25G Transconjunctival Sutureless Vitrectomy System Product Offerings
7.7.5 Beijing Kangruide Medical Technology Recent Developments
7.8 Shanghai New Vision Ophthalmic Equipment
7.8.1 Shanghai New Vision Ophthalmic Equipment Company Information
7.8.2 Shanghai New Vision Ophthalmic Equipment Introduction and Business Overview
7.8.3 Shanghai New Vision Ophthalmic Equipment 25G Transconjunctival Sutureless Vitrectomy System Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Shanghai New Vision Ophthalmic Equipment 25G Transconjunctival Sutureless Vitrectomy System Product Offerings
7.8.5 Shanghai New Vision Ophthalmic Equipment Recent Developments
7.9 Shenzhen Ophthalmic Equipment
7.9.1 Shenzhen Ophthalmic Equipment Company Information
7.9.2 Shenzhen Ophthalmic Equipment Introduction and Business Overview
7.9.3 Shenzhen Ophthalmic Equipment 25G Transconjunctival Sutureless Vitrectomy System Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Shenzhen Ophthalmic Equipment 25G Transconjunctival Sutureless Vitrectomy System Product Offerings
7.9.5 Shenzhen Ophthalmic Equipment Recent Developments
8 Industry Chain Analysis
8.1 25G Transconjunctival Sutureless Vitrectomy System Industrial Chain
8.2 25G Transconjunctival Sutureless Vitrectomy System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 25G Transconjunctival Sutureless Vitrectomy System Sales Model
8.5.2 Sales Channels
8.5.3 25G Transconjunctival Sutureless Vitrectomy System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. 25G Transconjunctival Sutureless Vitrectomy System Market Trends
Table 2. 25G Transconjunctival Sutureless Vitrectomy System Market Drivers & Opportunities
Table 3. 25G Transconjunctival Sutureless Vitrectomy System Market Challenges
Table 4. 25G Transconjunctival Sutureless Vitrectomy System Market Restraints
List of Figures
Figure 1. 25G Transconjunctival Sutureless Vitrectomy System Product Picture
Figure 2. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value (US$ Million), 2021–2032
Figure 4. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume (Units), 2021–2032
Figure 5. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Price (K US$/Unit), 2021–2032
Figure 6. 25G Transconjunctival Sutureless Vitrectomy System Report Years Considered
Figure 7. Global 25G Transconjunctival Sutureless Vitrectomy System Players Revenue Ranking (US$ Million), 2025
Figure 8. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume Ranking of Players (Units), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by 25G Transconjunctival Sutureless Vitrectomy System Revenue in 2025
Figure 10. 25G Transconjunctival Sutureless Vitrectomy System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Standard Picture
Figure 12. Combination Picture
Figure 13. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value Market Share by Type, 2025 & 2032
Figure 15. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume by Type (Units), 2021 vs 2025 vs 2032
Figure 16. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume Market Share by Type, 2025 & 2032
Figure 17. Global 25G Transconjunctival Sutureless Vitrectomy System Price by Type (K US$/Unit), 2021–2032
Figure 18. Product Picture of Ophthalmology
Figure 19. Product Picture of Other
Figure 20. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Value Market Share by Application, 2025 & 2032
Figure 22. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume by Application (Units), 2021 vs 2025 vs 2032
Figure 23. Global 25G Transconjunctival Sutureless Vitrectomy System Sales Volume Market Share by Application, 2025 & 2032
Figure 24. Global 25G Transconjunctival Sutureless Vitrectomy System Price by Application (K US$/Unit), 2021–2032
Figure 25. North America 25G Transconjunctival Sutureless Vitrectomy System Sales Value (US$ Million), 2021–2032
Figure 26. North America 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Country (%), 2025 vs 2032
Figure 27. Europe 25G Transconjunctival Sutureless Vitrectomy System Sales Value (US$ Million), 2021–2032
Figure 28. Europe 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Country (%), 2025 vs 2032
Figure 29. Asia Pacific 25G Transconjunctival Sutureless Vitrectomy System Sales Value (US$ Million), 2021–2032
Figure 30. Asia Pacific 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Region (%), 2025 vs 2032
Figure 31. South America 25G Transconjunctival Sutureless Vitrectomy System Sales Value (US$ Million), 2021–2032
Figure 32. South America 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Country (%), 2025 vs 2032
Figure 33. Middle East & Africa 25G Transconjunctival Sutureless Vitrectomy System Sales Value (US$ Million), 2021–2032
Figure 34. Middle East & Africa 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Country (%), 2025 vs 2032
Figure 35. Key Countries/Regions 25G Transconjunctival Sutureless Vitrectomy System Sales Value (%), 2021–2032
Figure 36. Key Countries/Regions 25G Transconjunctival Sutureless Vitrectomy System Sales Volume (%), 2021–2032
Figure 37. United States 25G Transconjunctival Sutureless Vitrectomy System Sales Value (US$ Million), 2021–2032
Figure 38. United States 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Type (%), 2025 vs 2032
Figure 39. United States 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Application (%), 2025 vs 2032
Figure 40. Europe 25G Transconjunctival Sutureless Vitrectomy System Sales Value (US$ Million), 2021–2032
Figure 41. Europe 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Type (%), 2025 vs 2032
Figure 42. Europe 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Application (%), 2025 vs 2032
Figure 43. China 25G Transconjunctival Sutureless Vitrectomy System Sales Value (US$ Million), 2021–2032
Figure 44. China 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Type (%), 2025 vs 2032
Figure 45. China 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Application (%), 2025 vs 2032
Figure 46. Japan 25G Transconjunctival Sutureless Vitrectomy System Sales Value (US$ Million), 2021–2032
Figure 47. Japan 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Type (%), 2025 vs 2032
Figure 48. Japan 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Application (%), 2025 vs 2032
Figure 49. South Korea 25G Transconjunctival Sutureless Vitrectomy System Sales Value (US$ Million), 2021–2032
Figure 50. South Korea 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Type (%), 2025 vs 2032
Figure 51. South Korea 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Application (%), 2025 vs 2032
Figure 52. Southeast Asia 25G Transconjunctival Sutureless Vitrectomy System Sales Value (US$ Million), 2021–2032
Figure 53. Southeast Asia 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Type (%), 2025 vs 2032
Figure 54. Southeast Asia 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Application (%), 2025 vs 2032
Figure 55. India 25G Transconjunctival Sutureless Vitrectomy System Sales Value (US$ Million), 2021–2032
Figure 56. India 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Type (%), 2025 vs 2032
Figure 57. India 25G Transconjunctival Sutureless Vitrectomy System Sales Value by Application (%), 2025 vs 2032
Figure 58. 25G Transconjunctival Sutureless Vitrectomy System Industrial Chain
Figure 59. 25G Transconjunctival Sutureless Vitrectomy System Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global 25G Transconjunctival Sutureless Vitrectomy System market?
The top companies in the global 25G Transconjunctival Sutureless Vitrectomy System market are Alcon、Bausch + Lomb、Dutch Ophthalmic Research Center.
Related Reports
Global 25G Transconjunctival Sutureless Vitrectomy System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global 25G Transconjunctival Sutureless Vitrectomy System market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 132
USD 4900.00
(Single User License)
Global 25G Transconjunctival Sutureless Vitrectomy System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global 25G Transconjunctival Sutureless Vitrectomy System market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 77
USD 4250.00
(Single User License)
Global 25G Transconjunctival Sutureless Vitrectomy System Market Research Report 2026
The global 25G Transconjunctival Sutureless Vitrectomy System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-08
Pages: 115
USD 2900.00
(Single User License)
Global 25G Transconjunctival Sutureless Vitrectomy System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global 25G Transconjunctival Sutureless Vitrectomy System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 141
USD 4900.00
(Single User License)
Global 25G Transconjunctival Sutureless Vitrectomy System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global 25G Transconjunctival Sutureless Vitrectomy System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 77
USD 4250.00
(Single User License)
25G Transconjunctival Sutureless Vitrectomy System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for 25G Transconjunctival Sutureless Vitrectomy System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 98
USD 3950.00
(Single User License)
Global 25G Transconjunctival Sutureless Vitrectomy System Market Research Report 2025
The global market for 25G Transconjunctival Sutureless Vitrectomy System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 87
USD 2900.00
(Single User License)
Global 25G Transconjunctival Sutureless Vitrectomy System Market Insights, Forecast to 2030
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
Published Date: 2024-10-31
Pages: 134
USD 4900.00
(Single User License)
25G Transconjunctival Sutureless Vitrectomy System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
Published Date: 2024-10-31
Pages: 100
USD 3950.00
(Single User License)
Global 25G Transconjunctival Sutureless Vitrectomy System Market Research Report 2024
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
Published Date: 2024-10-31
Pages: 80
USD 2900.00
(Single User License)
Global 25G Transconjunctival Sutureless Vitrectomy System Market Outlook, In‑Depth Analysis & Forecast to 2032
The global 25G Transconjunctival Sutureless Vitrectomy System market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 132
USD 4900.00 (Single User License)Global 25G Transconjunctival Sutureless Vitrectomy System Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global 25G Transconjunctival Sutureless Vitrectomy System market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 77
USD 4250.00 (Single User License)Global 25G Transconjunctival Sutureless Vitrectomy System Market Research Report 2026
The global 25G Transconjunctival Sutureless Vitrectomy System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-08
Pages: 115
USD 2900.00 (Single User License)Global 25G Transconjunctival Sutureless Vitrectomy System Market Outlook, In‑Depth Analysis & Forecast to 2031
The global 25G Transconjunctival Sutureless Vitrectomy System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 141
USD 4900.00 (Single User License)Global 25G Transconjunctival Sutureless Vitrectomy System Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global 25G Transconjunctival Sutureless Vitrectomy System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 77
USD 4250.00 (Single User License)25G Transconjunctival Sutureless Vitrectomy System - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for 25G Transconjunctival Sutureless Vitrectomy System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 98
USD 3950.00 (Single User License)Global 25G Transconjunctival Sutureless Vitrectomy System Market Research Report 2025
The global market for 25G Transconjunctival Sutureless Vitrectomy System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 87
USD 2900.00 (Single User License)Global 25G Transconjunctival Sutureless Vitrectomy System Market Insights, Forecast to 2030
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
Published: 2024-10-31
Pages: 134
USD 4900.00 (Single User License)25G Transconjunctival Sutureless Vitrectomy System- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
Published: 2024-10-31
Pages: 100
USD 3950.00 (Single User License)Global 25G Transconjunctival Sutureless Vitrectomy System Market Research Report 2024
The 25G transconjunctival sutureless vitrectomy system is a vitrectomy surgery performed with minimal trauma. It uses a special trocar to directly puncture the bulbar conjunctiva and sclera to enter the vitreous cavity for surgery. The surgical incision is significantly reduced and no suture is required, so it is called "minimally traumatic" surgery. The system is mainly composed of microcannulas, cannula puncture needles, perfusion tubes, cannula plugs and plug forceps. Among them, the diameters of the cannulas and surgical instruments are very small, so that only three very small needle holes (0.5 mm in diameter) are needed to pass through the wall of the eyeball. The perfusion tube and surgical instruments are inserted into the eyeball through the cannula, and no sutures are required to fix them.
Published: 2024-10-31
Pages: 80
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now